Katja Pecjak Reven, M.Sc. Pharm.

Owner, Subject Matter Expert for ePI, Head of Regulatory Affairs at Billev Pharma East

Speaker

Katja Pečjak Reven has over 20 years of experience in the pharmaceutical industry, specializing in regulatory affairs, eCTD, pharmacovigilance, and business development. She holds a degree from the University of Ljubljana and has led regulatory strategy, telematics projects, and pharmaceutical process solutions.

Currently, Katja Pečjak Reven focuses on business development at Billev Pharma East, driving growth and strengthening stakeholder relations. She has also been a Subject Matter Expert in the EMA ePI Pilot Project since July 2022. Katja is actively involved in professional groups such as Medicines for Europe, TOPRA, and the IRISS Forum, and in 2022, she took ownership of Billev Pharma East.